Vnitr Lek 2014, 60(3):187-188

Metabolic syndrome after kidney transplantation - editorial

Vladimír Teplan1,2
1 Klinika nefrologie IKEM Praha, přednosta prof. MUDr. Ondřej Viklický, CSc.
2 Subkatedra nefrologie IPVZ Praha, přednosta prof. MUDr. Vladimír Teplan, DrSc.

Received: December 4, 2013; Published: March 1, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Teplan V. Metabolic syndrome after kidney transplantation - editorial. Vnitr Lek. 2014;60(3):187-188.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Axelsson J, Heimbűrger O, Lindholm B et al. Adipose tissue and its relation to inflammation: the role of adipokines. J Renal Nutr 2005; 15(1): 131-136. Go to original source... Go to PubMed...
    2. Boger RH. Association of asymmetric dimethylarginine and endothelial dysfunction. Clin Chem Lab med 2003; 41(11): 1467-1472.
    3. Kielstein JT, Frölich JC, Haller H et al. ADMA: an atherosclerotic disease mediating agent in patients with renal disease? Nephrol Dial Transplant 2001; 16(9): 1742-1745. Go to original source... Go to PubMed...
    4. Pelikánová T. Metabolický syndrome. Vnitř Lék 2003; 49(12): 900-906. Go to PubMed...
    5. Teplan V, Schück O, Racek J et al. Asymmetric dimethylarginine and adiponectin after renal transplantation:role of obesity. J Ren Nutr 2008; 18(1): 154-157. Go to original source... Go to PubMed...
    6. Teplan V, Schück O, Stollova M et al. Obesity and Hyperhomocysteinemia after kidney transplantation. Nephrol Dial Transpl 2003; 18(Suppl 5): v71-v73. Go to original source... Go to PubMed...
    7. Wiecek A, Kokot F, Chudek J et al. The adipose tissue - a novel endocrine organ of interest to the nephrologist. Nephrol Dial Transpl 2002; 17(Suppl 2): 191-195. Go to original source... Go to PubMed...
    8. Zoccali C, Mallamaci F, Tripetpi G Adipose tissue as a source of inflammatory cytokines in health and disease: Focus and-stage renal disease. Kidney Int 2003; 63(Suppl 84): S65-S68. Go to original source... Go to PubMed...
    9. LaGuardia H, Zhang R Obesity and metabolic syndrome in kidney transplantation. Curr Hypertens Rep 2013; 15(3): 215-223. Go to original source... Go to PubMed...
    10. Hricik DE Metabolic syndrome in kidney transplantation: management of risk factors. Clin J Am Soc Nephrol 2011; 6(7): 1781-1785.
    11. Salerno MP, Piselli P, Rossi E et al. Metabolic syndrome and cardiovascular disease in kidney transplantation. Transp Proc 2011; 43(4): 1067-1068. Go to original source... Go to PubMed...
    12. Ordemir FN, Karaken S, Akgul A et al. Metabolic syndrome is related to long-term graft function in renal transplant recipients. Transpl Proc 2009; 41(7): 2808-2810. Go to original source... Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.